Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Liraglutide by Novo Nordisk for Obesity: Likelihood of Approval
Liraglutide is under clinical development by Novo Nordisk and currently in Phase III for Obesity. According to GlobalData, Phase III...
Data Insights
Liraglutide by Novo Nordisk for Alzheimer's Disease: Likelihood of Approval
Liraglutide is under clinical development by Novo Nordisk and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...